BEATTIE, Christopher,WADSWORTH, Anne,RENNIE, James
申请号：
HUE13737828
公开号：
HUE033330T2
申请日:
2013.07.11
申请国别(地区):
HU
年份:
2017
代理人:
摘要：
A porphyrin compound of Formula (1) is provided for use in cancer therapy that extends the period of time between the doses required while the patient is undergoing radiation therapy. The compound can be given not more often than once every 2 or more weeks, avoiding repeated administration, while radiation therapy can continue regularly.
